Form D — Tempest Therapeutics, Inc.
0001193125-26-278048 · filed Jun 23, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $4,056,552
- Reported amount sold
- $4,056,552
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Tempest Therapeutics, Inc.
- CIK
- 1544227
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, CA 94005 - Phone
- 415-798-8589
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Angel · Executive OfficerBrisbane, CA Find on LinkedIn ↗
-
Justin Trojanowski · Executive OfficerBrisbane, CA Find on LinkedIn ↗
-
John David Yee · DirectorBrisbane, CA Find on LinkedIn ↗
-
William Drake Richey · DirectorBrisbane, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗